Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Common Equity (2016 - 2025)

Historic Common Equity for Axogen (AXGN) over the last 16 years, with Q3 2025 value amounting to $120.8 million.

  • Axogen's Common Equity rose 2152.56% to $120.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.8 million, marking a year-over-year increase of 2152.56%. This contributed to the annual value of $103.9 million for FY2024, which is 861.55% up from last year.
  • As of Q3 2025, Axogen's Common Equity stood at $120.8 million, which was up 2152.56% from $112.3 million recorded in Q2 2025.
  • Over the past 5 years, Axogen's Common Equity peaked at $120.8 million during Q3 2025, and registered a low of $93.2 million during Q1 2024.
  • Its 5-year average for Common Equity is $104.9 million, with a median of $101.7 million in 2022.
  • As far as peak fluctuations go, Axogen's Common Equity tumbled by 1433.24% in 2022, and later surged by 2152.56% in 2025.
  • Quarter analysis of 5 years shows Axogen's Common Equity stood at $112.6 million in 2021, then dropped by 10.26% to $101.0 million in 2022, then fell by 5.28% to $95.7 million in 2023, then grew by 8.62% to $103.9 million in 2024, then rose by 16.26% to $120.8 million in 2025.
  • Its Common Equity was $120.8 million in Q3 2025, compared to $112.3 million in Q2 2025 and $105.4 million in Q1 2025.